4.5 Article

Correlation analysis between auto-immunological and mutational profiles in myelodysplastic syndromes

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Dermatology

Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients

S. Georgin-Lavialle et al.

Summary: VEXAS syndrome is a newly described autoinflammatory syndrome associated with somatic mutations of UBA1. It presents a wide range of clinical features, with different prognostic profiles identified, and the UBA1 p.Met41Leu mutation is associated with a better prognosis.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Article Hematology

Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry

Thibault Comont et al.

Summary: Azacitidine may be effective in MDS associated with inflammatory/autoimmune diseases. A study on 116 VEXAS patients in France found that azacitidine treatment achieved clinical response in 46% of patients, suggesting its potential effectiveness in selected VEXAS patients with MDS.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Oncology

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

Matteo Bersanelli et al.

Summary: The study identified eight distinct subgroups of MDS based on specific genomic features, each with different prognostic outcomes. By integrating clinical and genomic variables, a novel prognostic model was developed to provide personalized survival predictions for MDS patients. This model significantly improved the accuracy of current prognostic tools and has the potential to revolutionize disease classification and prognosis in the future.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Hematology

VEXAS syndrome

Peter C. Grayson et al.

Summary: VEXAS syndrome is a monogenic disease of adulthood caused by somatic mutations in UBA1, resulting in inflammatory and hematologic symptoms. Novel UBA1 genetic variants and treatment options were discussed in the recent issue of Blood, shedding light on disease pathophysiology. VEXAS syndrome serves as a prototype for a new class of diseases.
Review Immunology

Immune Phenomena in Myeloid Neoplasms: An Egg or Chicken Question

Wilma Barcellini et al.

Summary: Immune phenomena, including autoimmune diseases and immunodeficiency, are increasingly reported in myeloid neoplasms. These dysregulated immune responses may contribute to both tumor growth and infection susceptibility. Therapies aimed at boosting host immunity against tumors may lead to increased autoimmune complications.

FRONTIERS IN IMMUNOLOGY (2021)

Review Oncology

Autoimmune Complications in Hematologic Neoplasms

Wilma Barcellini et al.

Summary: This review discusses the occurrence and clinical features of autoimmune cytopenias and other autoimmune diseases in various lymphoid and myeloid neoplasms, highlighting the higher prevalence in certain subtypes and the challenges in diagnosis and management. It also emphasizes the complications in patients receiving hematopoietic stem cell transplant or new checkpoint inhibitors, with these complications impacting patient outcomes.

CANCERS (2021)

Article Oncology

Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia

Emiliano Fabiani et al.

Summary: ZBTB16-RARA+AML shows an intermediate number of mutations per patient and involvement of different genes. Particularly, a high incidence of ARID1A mutations was found in ZBTB16-RARA+AML.

CANCER MEDICINE (2021)

Review Oncology

Systemic adverse effects and toxicities associated with immunotherapy: A review

Asim Kichloo et al.

Summary: Immunotherapy is gaining popularity as a tumor-specific treatment and is becoming a key component in cancer management. However, with the increasing use of immunotherapeutic agents, physicians must familiarize themselves with and manage their adverse effects.

WORLD JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Oncology

The potentials of immune checkpoints for the treatment of blood malignancies

Mohsen Alizadeh et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)

Article Medicine, General & Internal

Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease

David B. Beck et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Hematology

Autoimmune manifestations associated with myelodysplastic syndromes

Eric Grignano et al.

ANNALS OF HEMATOLOGY (2018)

Article Medicine, General & Internal

Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation

R. C. Lindsley et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Hematology

Autoimmunity and inflammation in Myelodysplastic Syndromes

Ofir Wolach et al.

ACTA HAEMATOLOGICA (2016)

Article Hematology

Autoimmune diseases and myelodysplastic syndromes

Rami S. Komrokji et al.

AMERICAN JOURNAL OF HEMATOLOGY (2016)

Review Biochemistry & Molecular Biology

Immune Mechanisms in Myelodysplastic Syndrome

Andreas Glenthoj et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Review Immunology

A comprehensive review of myelodysplastic syndrome patients with autoimmune diseases

Stavroula Giannouli et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)

Article Medicine, General & Internal

Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

Giulio Genovese et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Medicine, General & Internal

Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes

Siddhartha Jaiswal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Rheumatology

Malignancy as a comorbidity in rheumatic diseases

Carl Turesson et al.

RHEUMATOLOGY (2013)

Article Rheumatology

Systemic and Immune Manifestations in Myelodysplasia: A Multicenter Retrospective Study

A. de Hollanda et al.

ARTHRITIS CARE & RESEARCH (2011)

Article Oncology

Risks of myeloid malignancies in patients with autoimmune conditions

L. A. Anderson et al.

BRITISH JOURNAL OF CANCER (2009)